Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HLT has climbed 12% over the past month to $345.12, and options traders are not hedging that gain. The put/call ratio has fallen to 0.70, more than two standard deviations below its 20-day average of 0.76, sitting near the lowest defensive reading of the past year. That is one of the more bullish options setups Hilton has shown ahead of a print in recent history. The borrow market adds no friction: shares available to borrow are effectively uncapped, and cost to borrow has fallen roughly 35% over the past week to 0.24%. Short interest of 2.4% of float, while edging up 8% over the past week, remains too small to represent a meaningful bearish conviction trade.
Analyst activity heading into Wednesday's release is skewed firmly positive. Barclays raised its target to $384 this week while maintaining Overweight, and Morgan Stanley lifted to $336 earlier in the month, also staying Overweight. The bull case rests on RevPAR growth running ahead of sector expectations for 2026, consistent EBITDA outperformance, and an asset-light franchise model that generates fee income with relatively little capital intensity. The factor score on analyst recommendation divergence ranks in the 93rd percentile across the ORTEX universe, meaning the Street is more aligned behind Hilton than it is behind almost any comparable name right now. Bears point to a crowded valuation: the stock trades at roughly 34x earnings and about 20.6x EV/EBITDA, with both multiples having expanded over the past month as the price rallied. Truist Securities, which carries a Hold rating, has a target at $316, well below where the stock closed Friday, and Susquehanna trimmed its target to $345 in August, flagging valuation as the main constraint.
Peer performance over the past week supports the positive tape. MAR rose 6.1% and IHG gained 6.9%, suggesting sector-level demand tailwinds rather than HLT-specific positioning driving the move. Insider activity is not a signal in the conventional sense here. The September filings were fractional director compensation grants, totalling fewer than 40 shares across eight board members, routine administrative awards rather than open-market conviction buys.
The print will test whether Hilton's fee-based revenue growth and pipeline expansion can justify a valuation that has expanded materially into the release, and whether the Street's rare near-consensus bullish positioning reflects fundamental momentum or leaves the stock exposed if guidance disappoints.
See the live data behind this article on ORTEX.
Open HLT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
